Skip to main content
. 2015 Dec 24;7(4):4399–4413. doi: 10.18632/oncotarget.6749

Figure 7. Sildenafil and DOX co-treatment reduces FAP-1 expression in DU 145 cells.

Figure 7

(A) Representative immunoblots for FAP-1 and Actin in DU145 cells after 48 hr of treatment with DOX (0.5 μM) and/or Sild (10 μM). (B) Densitometry analysis of the ratios of FAP-1 to Actin. Abbreviations: doxorubicin – DOX; Sildenafil – Sild.